ISLA-101
Dengue fever and Zika virus infection
Phase 2a/b ChallengeActive
Key Facts
Indication
Dengue fever and Zika virus infection
Phase
Phase 2a/b Challenge
Status
Active
Company
About Island Pharmaceuticals
Australian biotech repurposing antivirals for dengue and other vector‑borne diseases, with a Phase 2a/b trial of ISLA‑101.
View full company profile